Helius Medical Technologies Inc Class A
Solana Company operates as a listed digital asset treasury. It enhances SOL per share on the commercially viable blockchain for decentralized finance and consumer applications. The company is headquartered in Newtown, Pennsylvania.
Helius Medical Technologies Inc Class A (HSDT) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.027x
Based on the latest financial reports, Helius Medical Technologies Inc Class A (HSDT) has a cash flow conversion efficiency ratio of 0.027x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.04 Million) by net assets ($-152.39 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Helius Medical Technologies Inc Class A - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Helius Medical Technologies Inc Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Helius Medical Technologies Inc Class A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Helius Medical Technologies Inc Class A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
North European Oil Royalty Trust
NYSE:NRT
|
1.478x |
|
iBio, Inc. Common Stock
NASDAQ:IBIO
|
-0.093x |
|
CSP Inc
NASDAQ:CSPI
|
-0.065x |
|
United Health Products Inc
PINK:UEEC
|
0.074x |
|
Trajectory Alpha Acquisition Corp
NYSE:TCOA
|
-0.004x |
|
Daedong Gear Co. Ltd
KQ:008830
|
0.047x |
|
Chin Hin Group Property Bhd
KLSE:7187
|
-0.065x |
|
ASSOCIATED CAP. A DL-001
F:41J
|
N/A |
Annual Cash Flow Conversion Efficiency for Helius Medical Technologies Inc Class A (2013–2024)
The table below shows the annual cash flow conversion efficiency of Helius Medical Technologies Inc Class A from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $1.06 Million | $-11.04 Million | -10.426x | -135.22% |
| 2023-12-31 | $2.35 Million | $-10.42 Million | -4.432x | -152.47% |
| 2022-12-31 | $8.15 Million | $-14.31 Million | -1.756x | -47.60% |
| 2021-12-31 | $11.26 Million | $-13.39 Million | -1.189x | +60.78% |
| 2020-12-31 | $3.87 Million | $-11.74 Million | -3.032x | +15.74% |
| 2019-12-31 | $5.83 Million | $-21.00 Million | -3.599x | -80.74% |
| 2018-12-31 | $9.85 Million | $-19.62 Million | -1.991x | -177.17% |
| 2017-12-31 | $-7.49 Million | $-19.32 Million | 2.580x | -99.47% |
| 2016-12-31 | $-16.19K | $-7.94 Million | 490.176x | -0.01% |
| 2015-12-31 | $-16.19K | $-7.94 Million | 490.206x | +12020.05% |
| 2014-12-31 | $-1.56 Million | $-6.32 Million | 4.045x | +210.83% |
| 2013-12-31 | $-267.98K | $-348.70K | 1.301x | -- |